HB MIRDX Trademark

Trademark Overview


On Tuesday, March 17, 2020, a trademark application was filed for HB MIRDX with the United States Patent and Trademark Office. The USPTO has given the HB MIRDX trademark a serial number of 88837147. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Thursday, January 28, 2021. This trademark is owned by HeimBiotek, Inc.. The HB MIRDX trademark is filed in the Medical Instrument Products category with the following description:

medical diagnostic kits consisting primarily of medical diagnostic reagents for detection or quantitative analysis of BK virus infection or reactivation; medical diagnostic kits consisting primarily of medical diagnostic reagents for detection or quantitative analysis of kidney transplant rejection; medical diagnostic kits for consisting primarily of medical diagnostic reagents detection or quantitative analysis of Epstein-Barr virus infection; medical diagnostic kits consisting primarily of medical diagnostic reagents for detection or quantitative analysis of Cytomegalo virus infection; medical diagnostic kits for consisting primarily of medical diagnostic reagents prediction of targeted therapy efficacy for metastatic colorectal cancer; medical diagnostic kits consisting primarily of medical diagnostic reagents for prediction of targeted therapy efficacy for non-small cell lung cancer; medical diagnostic kits consisting primarily of medical diagnostic reagents for prognosis of liver ...
hb mirdx

General Information


Serial Number88837147
Word MarkHB MIRDX
Filing DateTuesday, March 17, 2020
Status730 - FIRST EXTENSION - GRANTED
Status DateThursday, January 28, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 18, 2020

Trademark Statements


Goods and Servicesmedical diagnostic kits consisting primarily of medical diagnostic reagents for detection or quantitative analysis of BK virus infection or reactivation; medical diagnostic kits consisting primarily of medical diagnostic reagents for detection or quantitative analysis of kidney transplant rejection; medical diagnostic kits for consisting primarily of medical diagnostic reagents detection or quantitative analysis of Epstein-Barr virus infection; medical diagnostic kits consisting primarily of medical diagnostic reagents for detection or quantitative analysis of Cytomegalo virus infection; medical diagnostic kits for consisting primarily of medical diagnostic reagents prediction of targeted therapy efficacy for metastatic colorectal cancer; medical diagnostic kits consisting primarily of medical diagnostic reagents for prediction of targeted therapy efficacy for non-small cell lung cancer; medical diagnostic kits consisting primarily of medical diagnostic reagents for prognosis of liver cancer after liver transplant; medical diagnostic kits consisting primarily of medical diagnostic reagents for detection or quantitative analysis of liver cancer; medical diagnostic kits consisting primarily of medical diagnostic reagents for detection or quantitative analysis of pancreatic cancer; medical diagnostic kits consisting primarily of medical diagnostic reagents for detection or quantitative analysis of lung cancer
Pseudo MarkHEIM BIO TECH MIRDX

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateSaturday, March 21, 2020
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameHeimBiotek, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeongnamsi Gyeonggi-do 13486
KR

Party NameHeimBiotek, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeongnamsi Gyeonggi-do 13486
KR

Trademark Events


Event DateEvent Description
Saturday, January 30, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 28, 2021EXTENSION 1 GRANTED
Thursday, January 28, 2021EXTENSION 1 FILED
Thursday, January 28, 2021TEAS EXTENSION RECEIVED
Tuesday, October 13, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 18, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 18, 2020PUBLISHED FOR OPPOSITION
Wednesday, July 29, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, July 15, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 10, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 10, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 8, 2020ASSIGNED TO LIE
Friday, June 26, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 10, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, June 10, 2020NON-FINAL ACTION E-MAILED
Wednesday, June 10, 2020NON-FINAL ACTION WRITTEN
Tuesday, June 9, 2020ASSIGNED TO EXAMINER
Saturday, March 21, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, March 20, 2020NEW APPLICATION ENTERED IN TRAM